XOMA XOMA Ltd. featured news, full reports, and detailed charts
XOMA Ltd. (XOMA) Wrap Up:
XOMA Ltd. (“XOMA” or the “Company”), a Bermuda company, is a leading biopharmaceutical company focused on the discovery, development and manufacture of therapeutic antibodies. XOMA uses its expertise, technologies and capabilities to build a product pipeline that includes multiple proprietary and collaborative development programs. The Company’s lead product candidate is XOMA 052, a high affinity anti-IL-1 beta antibody with the potential to treat multiple inflammatory diseases of large unmet need. XOMA 052 is currently in Phase 1 clinical studies of Type 2 diabetes patients. XOMA has multiple revenue streams and generates revenues from product royalties, technology licenses, development collaborations and biodefense contracts. ... More..."http://secfilings.nasdaq.com/edgar_conv_html%2f2008%2f03%2f11%2f0001193125-08-052901.html#FIS_BUSINESS"www.xoma.com
335 Employees
Founded in 1981
XOMA Ltd. (XOMA*(D):NASDAQ)
LAST $0.74 USD
CHANGE TODAY -0.051 -6.46%
VOLUME 2.4M
*(D) = Deficient: Issuer Failed to Meet NASDAQ Continued Listing Requirements
As of 4:00 PM 11/20/09 All times are local (Market data by Reuters is delayed by at least 15 minutes).
Snapshot of XOMA Ltd. (XOMA)
|
OPEN
$0.70
|
PREVIOUS CLOSE
$0.79
|
|
|
DAY HIGH
$0.76
|
DAY LOW
$0.70
|
|
|
52 WEEK HIGH
06/8/09 - $1.34
|
52 WEEK LOW
03/12/09 - $0.37
|
|
|
MARKET CAP
147.0M
|
AVERAGE VOLUME 3 mo
2.2M
|
|
|
DILUTED EPS TTM
$0.06
|
SHARES OUTSTANDING
198.9M
|
|
|
XOMA Does Not Pay Dividends
|
P/E TTM
12.5x
|
|
| K = Thousands M = Millions B = Billions | ||
related news
XOMA Appoints Jim Neal Vice President Of Business Development
Investrend - 11/18/2009 11:28 AM ET
XOMA Top Compensated Officers
Mr. Steven B. Engle
Chairman, Chief Executive Officer and Preside...
Age: 54
Total Annual Compensation: $515.0K
Dr. Patrick J. Scannon M.D., Ph.D.
Founder, Chief Medical Officer, Executive Vic...
Age: 61
Total Annual Compensation: $370.8K
Mr. Fred Kurland
Chief Financial Officer and Vice President of...
Age: 58
Total Annual Compensation: --
Mr. Robert S. Tenerowicz
Vice President of Operations and Head of the ...
Age: 46
Total Annual Compensation: $270.0K
Mr. Christopher J. Margolin Esq.
Vice President, Secretary, General Counsel an...
Age: 62
Total Annual Compensation: $322.4K
Executives, Board Directors
Compensation as of Fiscal Year 2008.
Key developments for XOMA Ltd. (XOMA)
XOMA Ltd. to Report Q3, 2009 Results on November 09, 2009
11/3/2009
XOMA Ltd. announced that they will report Q3, 2009 results before the start of trading on November 09, 2009.
XOMA Ltd., Q3 2009 Earnings Call, Nov--09-2009
11/3/2009
XOMA Ltd., Q3 2009 Earnings Call, Nov-09-2009
XOMA Ltd. expected to Report Fiscal Year 2009 Results on March 8, 2010. This event was calculated by Capital IQ (Created on November 3, 2009).
11/3/2009
XOMA Ltd. expected to Report Fiscal Year 2009 Results on March 8, 2010. This event was calculated by Capital IQ (Created on November 3, 2009).
XOMA Competitors
| Company | Last | Change |
| Celera Group | $6.25 USD | -0.05 |
| Diamyd Medical AB | kr146.25 SEK | -1.75 |
| Dyax Corp | $3.91 USD | +0.26 |
| QLT Inc | C$3.91 CAD | -0.04 |
| Seattle Genetics Inc | $9.30 USD | -0.04 |
| Market data is delayed at least 20 minutes. | ||
Industry Analysis
| Valuation | XOMA | Industry Range |
| Price/Earnings | 14.5x |
|
| Price/Sales | 1.1x |
|
| Price/Book | 13.6x |
|
| Price/Cash Flow | 19.5x |
|
| TEV/Sales | 0.9x |
|
|
XOMA |
||
|
XOMA transactions
| Type Date |
Target |
|
Private Placement
June 5, 2009 |
-- |
More Recent News About XOMA Ltd.
Would you like to leave a comment about XOMA Ltd. XOMA
Find out what social network information about XOMA Ltd. are available on RealpenniesWorst 5 - Click here to find out what stocks have been voted down by our visitors and users
Besides XOMA Ltd. there is more great information available at Realpennies.com